CN103611078A - Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof - Google Patents
Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof Download PDFInfo
- Publication number
- CN103611078A CN103611078A CN201310620347.1A CN201310620347A CN103611078A CN 103611078 A CN103611078 A CN 103611078A CN 201310620347 A CN201310620347 A CN 201310620347A CN 103611078 A CN103611078 A CN 103611078A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine liquid
- oral traditional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 26
- 239000007788 liquid Substances 0.000 title claims abstract description 25
- 230000001684 chronic effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 240000009087 Crescentia cujete Species 0.000 claims description 5
- 235000005983 Crescentia cujete Nutrition 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 235000009797 Lagenaria vulgaris Nutrition 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 240000001980 Cucurbita pepo Species 0.000 abstract 1
- 235000009852 Cucurbita pepo Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 235000014266 Geum aleppicum Nutrition 0.000 abstract 1
- 241000123870 Geum aleppicum Species 0.000 abstract 1
- 241000219991 Lythraceae Species 0.000 abstract 1
- 244000183278 Nephelium litchi Species 0.000 abstract 1
- 235000015742 Nephelium litchi Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006677 Vicia faba Species 0.000 abstract 1
- 235000010749 Vicia faba Nutrition 0.000 abstract 1
- 235000002098 Vicia faba var. major Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 208000007893 Salpingitis Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010061041 Chlamydial infection Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and a preparation method thereof. The oral traditional Chinese medicine liquid is prepared from the following raw materials in parts by weight: 10 to 15 parts of angelica sinensis, 20 to 30 parts of the root of red-rooted salvia, 15 to 20 parts of root of common peony, 5 to 10 parts of lychee seeds, 12 to 18 parts of rhizoma corydalis, 10 to 15 parts of broadbean flower, 14 to 22 parts of rhizoma sparganii, 8 to 12 parts of curcuma zedoary, 5 to 10 parts of aleppo avens, 18 to 24 parts of patrinia, 9 to 16 parts of sargent gloryvine, 5 to 10 parts of golden cypress, 20 to 30 parts of poria cocos, 15 to 20 parts of loosestrife, 6 to 11 parts of rhizoma cyperi, 12 to 18 parts of tsubaki root bark and 5 to 10 parts of gourd shell. The oral traditional Chinese medicine liquid has the functions of clearing heat, promoting diuresis, activating blood, dissolving stasis, regulating the flow of vital energy, removing obstruction stasis as well as relieving swelling and pain, and is stable in efficacy, good in treatment effect, short in treatment course, high in cure rate and low in recurrence rate and cannot generate toxic side effects and adverse reactions. Thus, the oral traditional Chinese medicine liquid is safe and reliable. The total effective rate of the oral traditional Chinese medicine liquid reaches more than 95% when the oral traditional Chinese medicine liquid is used for treating the chronic pelvic inflammation caused by dampness-heat and stasis. In addition, the oral traditional Chinese medicine liquid is simple to take and low in cost. Thus, the oral traditional Chinese medicine liquid is worthy of clinical popularization and application.
Description
Technical field
The present invention relates to a kind of Chinese medicine oral liquid, be specifically related to a kind of Chinese medicine oral liquid for the treatment of chronic pelvic inflammatory disease and preparation method thereof.
Background technology
Chronic pelvic inflammatory disease is a kind of common gynaecopathia, is female internal genital organs and around connective tissue, pelvic peritoneal chronic inflammatory disease; Normal is not thoroughly treatment of acute pelvic inflammatory disease, and in the situation that patient's body constitution is poor, the course of disease of acute pelvic inflammatory disease can be delayed and outbreak repeatedly, causes chronic pelvic inflammatory disease; But also can be without acute pelvic inflammatory disease disease medical history process, as salpingitis due to chlamydia trachomatis infection.The chronic pelvic inflammatory disease state of an illness is more obstinate, can cause menoxenia, leucorrhoea grow in quantity, dysmenorrhea, infertile, mass in the abdomen etc.Western medicine because of long-time use antibiotic therapy easily cause collective's dysbacteriosis and toxic and side effects large, therefore use Chinese medicine preparation substitute antibiotics treatment chronic pelvic inflammatory disease, yet the Chinese medicine preparation for the treatment of in the market chronic pelvic inflammatory disease exists the problems such as therapeutic effect is poor, cure rate is low, relapse rate is high now.
Summary of the invention
The object of the invention is to the problems such as poor for the therapeutic effect of existing Chinese medicine preparation existence, cure rate is low, relapse rate is high, Chinese medicine oral liquid of the treatment chronic pelvic inflammatory disease that provide a kind of good effect, short treating period, cure rate is high, relapse rate is low, has no side effect, has no adverse reaction and preparation method thereof.
For achieving the above object, the technical solution used in the present invention is as follows:
Treat a Chinese medicine oral liquid for chronic pelvic inflammatory disease, by the raw material of following weight portion, made: Radix Angelicae Sinensis 10-15, Radix Salviae Miltiorrhizae 20-30, Radix Paeoniae Rubra 15-20, Semen Litchi 5-10, Rhizoma Corydalis 12-18, Flos Viciae fabae 10-15, Rhizoma Sparganii 14-22, Rhizoma Curcumae 8-12, Radix seu Herba Gei aleppici 5-10, Herba Patriniae 18-24, Caulis Sargentodoxae 9-16, Cortex Phellodendri 5-10, Poria 20-30, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15-20, Rhizoma Cyperi 6-11, Cortex Ailanthi 12-18, calabash shell 5-10.
Preferably, treat a Chinese medicine oral liquid for chronic pelvic inflammatory disease, by the raw material of following weight portion, made: Radix Angelicae Sinensis 15, Radix Salviae Miltiorrhizae 20, Radix Paeoniae Rubra 20, Semen Litchi 8, Rhizoma Corydalis 16, Flos Viciae fabae 10, Rhizoma Sparganii 18, Rhizoma Curcumae 10, Radix seu Herba Gei aleppici 8, Herba Patriniae 22, Caulis Sargentodoxae 13, Cortex Phellodendri 7, Poria 25, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15, Rhizoma Cyperi 9, Cortex Ailanthi 14, calabash shell 6.
A preparation method for the treatment of the Chinese medicine oral liquid of chronic pelvic inflammatory disease, comprises the following steps:
(1) by formulation ratio, weigh and get each component, mix homogeneously, pulverized 100-150 mesh sieve, added and was equivalent to mixed-powder weight 4-8 water doubly, micro-boiling decocts 1-2h, filters, and filtering residue adds the water that 3-5 doubly measures again, micro-boiling decocts 0.5-1h, filters merging filtrate, be concentrated in right amount, let cool, add ethanol and make precipitation, place 24-36h, get supernatant decompression recycling ethanol, add water and stir evenly, standing, to get supernatant and filter, filtrate is concentrated;
(2) in the above-mentioned concentrated solution making, add the Mel of 20-30% to stir, filter, sub-bottle fill, 10 milliliters every bottle, sealing, sterilizing, packing, gets product.
Usage and consumption: oral, a 10ml, 2-3 time on the one.
Beneficial effect of the present invention: Chinese medicine oral liquid of the present invention has clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling, the effect of the eliminating stagnation of regulating the flow of vital energy, reducing swelling and alleviating pain, and drug effect is steady, good effect, short treating period, cure rate is high, and relapse rate is low, have no side effect, have no adverse reaction, safe and reliable, be used for the treatment of because of the chronic pelvic inflammatory disease due to damp and hot stasis, total effective rate reaches more than 95%, and take simply, cost is low, and clinic is applied.
The specific embodiment
treat a Chinese medicine oral liquid for chronic pelvic inflammatory disease, by the raw material of following weight (g), made: Radix Angelicae Sinensis 15, Radix Salviae Miltiorrhizae 20, Radix Paeoniae Rubra 20, Semen Litchi 8, Rhizoma Corydalis 16, Flos Viciae fabae 10, Rhizoma Sparganii 18, Rhizoma Curcumae 10, Radix seu Herba Gei aleppici 8, Herba Patriniae 22, Caulis Sargentodoxae 13, Cortex Phellodendri 7, Poria 25, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15, Rhizoma Cyperi 9, Cortex Ailanthi 14, calabash shell 6.
A preparation method for the treatment of the Chinese medicine oral liquid of chronic pelvic inflammatory disease, comprises the following steps:
(1) by formulation ratio, weigh and get each component, mix homogeneously, pulverized 150 mesh sieves, added the water that is equivalent to 6 times of mixed-powder weight, micro-boiling decocts 1.5h, filters, and filtering residue adds the water of 4 times of amounts again, micro-boiling decocts 40min, filters merging filtrate, be concentrated in right amount, let cool, add ethanol and make precipitation, place 24h, get supernatant decompression recycling ethanol, add water and stir evenly, standing, to get supernatant and filter, filtrate is concentrated;
(2) in the above-mentioned concentrated solution making, add 25% Mel to stir, filter, sub-bottle fill, 10 milliliters every bottle, sealing, sterilizing, packing, gets product.
Usage and consumption: oral, a 10ml, 2-3 time on the one.
Model case:
Case 1: model, female, 35 years old.First visit on August 18 in 2011.More than miscarriage February, distention and pain in the lower abdomen, left side is for very, and profuse leukorrhea color is white, and Western medicine diagnose is salpingitis, pelvic inflammatory disease.Red tongue with yellow fur, stringy pulse faciola number, dialectical genus traditional Chinese medical science stagnated heat of liver channel, damp invasion of lower energizer.Control and work as regulating qi and dredging collateral, clearing away heat and eliminating dampness.Within 2011, JIUYUE starts to take oral liquid of the present invention on the 8th, and every day 3 times, a 10ml, took after 3 days, and stomachache slows down, and leucorrhea reduces, and continues to take after 4 days, and stomachache heals, and leucorrhea disappears.After half a year, follow up a case by regular visits to, not recurrence.
Case 2: money, female, 38 years old, first visit on April 6 in 2011.Leukorrhagia is red white, and more than distention and pain in the lower abdomen uncomfortable February, companion's soreness of waist is weak, through hospital diagnosis, is chronic pelvic inflammatory disease, once takes Chinese medicine and western medicine multiple, invalid.Within the next few days, soreness of waist stomachache increases the weight of, and leukorrhagia is sticky, red double mutually in vain, constipation with dry stool, and inappetence, sees its yellowish complexion and becomes thin, the abdominal part distension touching, slippery and rapid pulse, red tongue with yellow fur, this is stagnation of QI in lower-JIAO, the event of damp and hot heap soil or fertilizer over and around the roots knot, controls when clearing away heat and eliminating dampness, the eliminating stagnation of regulating the flow of vital energy.On April 20th, 2011 starts to take oral liquid of the present invention, and every day 2 times, a 10ml, took medicine after 4 days, and abdominal distention and pain obviously alleviates, leukorrhagia reduces, and diet is promoted, red tongue with thin and yellow fur, and a little less than soft pulse, the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is stagnant to be gone, continue to take medicine after 5 days, leukorrhagia disappears, without stomachache, spiritual diet amelioration.After half a year, follow up a case by regular visits to, not recurrence.
Case 3: poplar, female, 32 years old, first visit on October 22 in 2011.Bimester before feel hypogastralgia, leucorrhoea grow in quantity, menoxenia after pressed on ring.Recently symptom increases the weight of, and leucorrhea yellow skin amount is many, and stench is unpleasant, companion's frequent micturition, urgent micturition, and red tongue, thick, yellow and greasy fur, slippery and rapid pulse, is diagnosed as chronic pelvic inflammatory disease on inspection.On November 5th, 2011 starts to take oral liquid of the present invention, and every day 3 times, a 10ml, took medicine after 3 days, and symptom obviously alleviates, and abdominal pain alleviates, and the yellow amount of leucorrhea reduces, and continues to take after 5 days, and all diseases disappear, recovery from illness.After half a year, follow up a case by regular visits to, not recurrence.
Claims (3)
1. a Chinese medicine oral liquid for the treatment of chronic pelvic inflammatory disease, it is characterized in that, by the raw material of following weight portion, made: Radix Angelicae Sinensis 10-15, Radix Salviae Miltiorrhizae 20-30, Radix Paeoniae Rubra 15-20, Semen Litchi 5-10, Rhizoma Corydalis 12-18, Flos Viciae fabae 10-15, Rhizoma Sparganii 14-22, Rhizoma Curcumae 8-12, Radix seu Herba Gei aleppici 5-10, Herba Patriniae 18-24, Caulis Sargentodoxae 9-16, Cortex Phellodendri 5-10, Poria 20-30, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15-20, Rhizoma Cyperi 6-11, Cortex Ailanthi 12-18, calabash shell 5-10.
2. a kind of Chinese medicine oral liquid for the treatment of chronic pelvic inflammatory disease according to claim 1, it is characterized in that, by the raw material of following weight portion, made: Radix Angelicae Sinensis 15, Radix Salviae Miltiorrhizae 20, Radix Paeoniae Rubra 20, Semen Litchi 8, Rhizoma Corydalis 16, Flos Viciae fabae 10, Rhizoma Sparganii 18, Rhizoma Curcumae 10, Radix seu Herba Gei aleppici 8, Herba Patriniae 22, Caulis Sargentodoxae 13, Cortex Phellodendri 7, Poria 25, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15, Rhizoma Cyperi 9, Cortex Ailanthi 14, calabash shell 6.
3. a preparation method for the Chinese medicine oral liquid for the treatment of chronic pelvic inflammatory disease as claimed in claim 1 or 2, is characterized in that comprising the following steps:
(1) by formulation ratio, weigh and get each component, mix homogeneously, pulverized 100-150 mesh sieve, added and was equivalent to mixed-powder weight 4-8 water doubly, micro-boiling decocts 1-2h, filters, and filtering residue adds the water that 3-5 doubly measures again, micro-boiling decocts 0.5-1h, filters merging filtrate, be concentrated in right amount, let cool, add ethanol and make precipitation, place 24-36h, get supernatant decompression recycling ethanol, add water and stir evenly, standing, to get supernatant and filter, filtrate is concentrated;
(2) in the above-mentioned concentrated solution making, add the Mel of 20-30% to stir, filter, sub-bottle fill, 10 milliliters every bottle, sealing, sterilizing, packing, gets product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310620347.1A CN103611078A (en) | 2013-11-29 | 2013-11-29 | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310620347.1A CN103611078A (en) | 2013-11-29 | 2013-11-29 | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103611078A true CN103611078A (en) | 2014-03-05 |
Family
ID=50161811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310620347.1A Pending CN103611078A (en) | 2013-11-29 | 2013-11-29 | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103611078A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547964A (en) * | 2015-02-13 | 2015-04-29 | 范江诺 | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease |
| CN109663011A (en) * | 2019-03-05 | 2019-04-23 | 莱芜职业技术学院 | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703668A (en) * | 2009-10-23 | 2010-05-12 | 成莉 | Nano-silver infrared antibacterial aloe fabric umbilical cord for preventing pelvic inflammation |
| CN102631641A (en) * | 2012-04-26 | 2012-08-15 | 卢培玲 | Clysis liquid for treating pelvic inflammation |
-
2013
- 2013-11-29 CN CN201310620347.1A patent/CN103611078A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703668A (en) * | 2009-10-23 | 2010-05-12 | 成莉 | Nano-silver infrared antibacterial aloe fabric umbilical cord for preventing pelvic inflammation |
| CN102631641A (en) * | 2012-04-26 | 2012-08-15 | 卢培玲 | Clysis liquid for treating pelvic inflammation |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547964A (en) * | 2015-02-13 | 2015-04-29 | 范江诺 | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease |
| CN109663011A (en) * | 2019-03-05 | 2019-04-23 | 莱芜职业技术学院 | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102688420B (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN104042737A (en) | External medicinal composition for treating acute eczema and preparation method thereof | |
| CN103611078A (en) | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof | |
| CN103919966B (en) | A kind of medicine treating acne | |
| CN102205096B (en) | Medicament for treating adnexitis and pelvic inflammation | |
| CN102225118B (en) | Blood-activating wind-dispelling liquid | |
| CN101919977A (en) | Traditional Chinese medicine for treating arthromeningitis | |
| CN105214010A (en) | A kind of Chinese medicine preparation for the treatment of chronic cholecystitis | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN101637548B (en) | Medicine for treating kidney stone and preparation method thereof | |
| CN103536855A (en) | Traditional Chinese medicinal prescription for treating kidney stones and preparation method thereof | |
| CN103301305A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN104622995A (en) | Pharmaceutical composition for treating chronic superficial gastritis and preparation method of pharmaceutical composition | |
| CN103479960A (en) | Chronic Hepatitis B disease treatment Chinese herbal | |
| CN104027430A (en) | Traditional Chinese medicine composition for treating blood stasis type uterine myoma | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN103349767B (en) | Inula nervosa Wall oil capsule preparation and preparation method thereof | |
| CN102940814B (en) | Medicine for treating tubal nowhere | |
| CN102861227B (en) | Traditional Chinese medicine composition for treating suppurative meningitis sequelae and preparation method of traditional Chinese medicine composition | |
| CN100544756C (en) | A kind of Chinese medicinal soft capsule for the treatment of acute mastitis and preparation method thereof | |
| CN106620246A (en) | Traditional Chinese medicine formula for treating diabetes cerebrovascular diseases | |
| CN106581476A (en) | Traditional Chinese medicine formula for treating diabetes | |
| CN104800315A (en) | Traditional Chinese medicine for treating pelvic floor muscle cramp syndrome | |
| CN1337250A (en) | Compound Wuduqing capsule of blister beetle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140305 |